Entag, Baby Boy .

HRN: 25-63-07  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2024
CEFUROXIME 750MG (VIAL)
08/07/2024
08/14/2024
IVT
270 MG
Q8H
SCALD BURN
Waiting Final Action 
08/07/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/07/2024
08/14/2024
TOPICAL
1%
BID
SCALD BURN
Waiting Final Action 
08/10/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/10/2024
08/16/2024
TOPICAL
1%
BID
Scald Burn
Waiting Final Action 
08/13/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/13/2024
08/22/2024
TOPICAL
1%
BID
Scald Burn
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: